| Item Type | Name |
|
Concept
|
Carcinoma, Non-Small-Cell Lung
|
|
Concept
|
Lung Neoplasms
|
|
Concept
|
Lung Diseases
|
|
Concept
|
Small Cell Lung Carcinoma
|
|
Concept
|
Lung
|
|
Academic Article
|
Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer.
|
|
Academic Article
|
Clinical Prediction of Pathologic Complete Response in Superior Sulcus Non-Small Cell Lung Cancer.
|
|
Academic Article
|
SABR vs surgery for NSCLC in the media.
|
|
Academic Article
|
Stage I lung cancer-to operate or to radiate? That is the question
|
|
Academic Article
|
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy
|
|
Academic Article
|
Image analysis-based assessment of PD-L1 and tumor-associated immune cells density supports distinct intratumoral microenvironment groups in non-small cell lung carcinoma patients
|
|
Academic Article
|
Variants with a low allele frequency detected in genomic DNA affect the accuracy of mutation detection in cell-free DNA by next-generation sequencing.
|
|
Academic Article
|
Results of Postdischarge Nursing Telephone Assessments: Persistent Symptoms Common Among Pulmonary Resection Patients.
|
|
Academic Article
|
Lack of Association Between Dexamethasone and Long-Term Survival After Non-Small Cell Lung Cancer Surgery.
|
|
Academic Article
|
Image Analysis-based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non-small Cell Lung Carcinoma Patients.
|
|
Academic Article
|
Stage I lung cancer-to operate or to radiate? that is the question.
|
|
Academic Article
|
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study.
|
|
Academic Article
|
Radiation Therapy is Independently Associated with Worse Survival After R0-Resection for Stage I-II Non-small Cell Lung Cancer: An Analysis of the National Cancer Data Base.
|
|
Academic Article
|
Salvage pulmonary resection after stereotactic body radiotherapy: A feasible and safe option for local failure in selected patients.
|
|
Academic Article
|
The Influence of Body Mass Index on Overall Survival?Following Surgical Resection of Non-Small Cell Lung Cancer.
|
|
Academic Article
|
Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells.
|
|
Academic Article
|
Long-Term Outcomes of Salvage Stereotactic Ablative?Radiotherapy for Isolated Lung Recurrence of Non-Small Cell Lung Cancer: A Phase II Clinical Trial.
|
|
Academic Article
|
Clinicopathologic and genetic features of primary bronchopulmonary mucoepidermoid carcinoma: the MD Anderson Cancer Center experience and comprehensive review of the literature.
|
|
Academic Article
|
TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical Recurrence.
|
|
Academic Article
|
Perioperative Outcomes of Patients Undergoing Lobectomy on Clopidogrel.
|
|
Academic Article
|
Reply to "Influence of Body Mass Index on Overall Survival Following Surgical Resection of Non-Small Cell Lung Cancer: Methodological Issues".
|
|
Academic Article
|
Prophylactic Cranial Irradiation Following Surgical Resection of Early-Stage Small-Cell Lung Cancer: A Review of the Literature.
|
|
Academic Article
|
Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching Analysis.
|
|
Academic Article
|
Programmed Death Cell Ligand 1 (PD-L1) Is Associated With Survival in Stage I Non-Small Cell Lung Cancer.
|
|
Academic Article
|
Development and Validation of a Predictive Radiomics Model for Clinical Outcomes in Stage I Non-small Cell Lung Cancer.
|
|
Academic Article
|
TRACERx: Tracking tumor evolution to impact the course of lung cancer.
|
|
Academic Article
|
Genetic variants in cytokine signaling pathways and clinical outcomes in early-stage lung cancer patients.
|
|
Academic Article
|
Barriers to Combined-Modality Therapy for Limited-Stage Small Cell Lung Cancer.
|
|
Academic Article
|
Reply to S.E. Vogl.
|
|
Academic Article
|
Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer.
|
|
Academic Article
|
Immunohistochemical and Image Analysis-Based Study Shows That Several Immune Checkpoints are Co-expressed in Non-Small Cell Lung Carcinoma Tumors.
|
|
Academic Article
|
Enhanced Recovery Decreases Pulmonary and Cardiac Complications After Thoracotomy for Lung Cancer.
|
|
Academic Article
|
Clinicoradiographic Predictors of Aggressive Biology in Lung Cancer With Ground Glass Components.
|
|
Academic Article
|
Natural History of Ground-Glass Lesions Among Patients With Previous Lung Cancer.
|
|
Academic Article
|
Prognostic Value of PD-L1 mRNA Sequencing Expression Profile in Non-Small Cell Lung Cancer.
|
|
Academic Article
|
Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma.
|
|
Academic Article
|
Induction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung Cancer.
|
|
Academic Article
|
TUSC2 Immunogene Therapy Synergizes with Anti-PD-1 through Enhanced Proliferation and Infiltration of Natural Killer Cells in Syngeneic Kras-Mutant Mouse Lung Cancer Models.
|
|
Academic Article
|
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC).
|
|
Academic Article
|
Perioperative Outcomes for Stage I Non-Small Cell Lung Cancer: Differences Between Men and Women.
|
|
Academic Article
|
Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation.
|
|
Academic Article
|
Effect of neoadjuvant chemotherapy on the immune microenvironment in non-small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches.
|
|
Academic Article
|
Local Recurrence After Microwave Ablation of Lung Malignancies: A Systematic Review.
|
|
Academic Article
|
Surgical margins and risk of local recurrence after wedge resection of colorectal pulmonary metastases.
|
|
Academic Article
|
Ground Glass Lesions on Chest Imaging: Evaluation of Reported Incidence in Cancer Patients Using Natural Language Processing.
|
|
Academic Article
|
Centrally located lung cancer and risk of?occult nodal disease: an objective evaluation of multiple definitions of tumour centrality with dedicated imaging software.
|
|
Academic Article
|
Multimodality Therapy for N2 Non-Small Cell Lung Cancer: An Evolving Paradigm.
|
|
Academic Article
|
Lung Cancer Patient Perceptions of the Value of an Outreach Thoracic Surgical Clinic.
|
|
Academic Article
|
Enhanced recovery after thoracic surgery is associated with improved adjuvant chemotherapy completion for non-small cell lung cancer.
|
|
Academic Article
|
Robotic-Assisted Lobectomy for Non-Small Cell Lung Cancer: A Comprehensive Institutional Experience.
|
|
Academic Article
|
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study.
|
|
Academic Article
|
Persistent opioid use is associated with worse survival after lobectomy for stage I non-small cell lung cancer.
|
|
Academic Article
|
A Proposed System Toward Standardizing Surgical-Based Treatments for Malignant Pleural Mesothelioma, From the Joint National Cancer Institute-International Association for the Study of Lung Cancer-Mesothelioma Applied Research Foundation Taskforce.
|
|
Academic Article
|
Glutathione reductase (GSR) gene deletion and chromosome 8 aneuploidy in primary lung cancers detected by fluorescence in situ hybridization.
|
|
Academic Article
|
Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice.
|
|
Academic Article
|
Colorectal cancer mutations are associated with survival and recurrence after pulmonary metastasectomy.
|
|
Academic Article
|
Local failure after stereotactic body radiation therapy or wedge resection for colorectal pulmonary metastases.
|
|
Academic Article
|
Commentary: Salvage Resection for Stage IIIA Lung Cancer in the Era of Immunotherapy.
|
|
Academic Article
|
Persistent Opioid Use Among the Elderly After Lung Resection: A SEER-Medicare Study.
|
|
Academic Article
|
Improved Overall Survival With Comprehensive Local Consolidative Therapy in Synchronous Oligometastatic Non-Small-Cell Lung Cancer.
|
|
Academic Article
|
Return to intended oncologic treatment after surgery for malignant pleural mesothelioma.
|
|
Academic Article
|
Time Trends of Perioperative Outcomes in Early Stage Non-Small Cell Lung Cancer Resection Patients.
|
|
Academic Article
|
Lymphovascular Invasion Is Associated With Mutational Burden and PD-L1 in Resected Lung Cancer.
|
|
Academic Article
|
Commentary: Surgery for N3 non-small cell lung cancer-utopia or future reality?
|
|
Academic Article
|
Commentary: Neoadjuvant checkpoint inhibitors in resectable non-small cell lung cancer-Ready for prime time?
|
|
Academic Article
|
Preoperative Heparin for Lung Cancer Resection Increases Risk of Reoperation for Bleeding.
|
|
Academic Article
|
Surveillance After Treatment of Non-Small-Cell Lung Cancer: A Call for Multidisciplinary Standardization.
|
|
Academic Article
|
Comprehensive T cell repertoire characterization of non-small cell lung cancer.
|
|
Academic Article
|
High mutational concordance between primary colorectal tumors and associated pulmonary metastases.
|
|
Academic Article
|
Locoregional Control, Overall Survival, and Disease-Free Survival in Stage IIIA (N2) Non-Small-Cell Lung Cancer: Analysis of Resected and Unresected Patients.
|
|
Academic Article
|
Typical and atypical carcinoid tumors of the lung: a clinicopathological correlation of 783 cases with emphasis on histological features.
|
|
Academic Article
|
A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non-Small Cell Lung Cancer.
|
|
Academic Article
|
Matched Pairs Comparison of an Enhanced Recovery Pathway Versus Conventional Management on Opioid Exposure and Pain Control in Patients Undergoing Lung Surgery.
|
|
Academic Article
|
Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy.
|
|
Academic Article
|
Pulmonary resection is associated with long-term survival and should remain a therapeutic option in oligometastatic lung cancer.
|
|
Academic Article
|
18F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer.
|
|
Academic Article
|
Reply to Waller et?al. Standardizing Surgical Treatment for Mesothelioma.
|
|
Academic Article
|
Neutrophil expansion defines an immunoinhibitory peripheral and intratumoral inflammatory milieu in resected non-small cell lung cancer: a descriptive analysis of a prospectively immunoprofiled cohort.
|
|
Academic Article
|
Time trends and predictors of survival in surgically resected early-stage non-small cell lung cancer patients.
|
|
Academic Article
|
Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC.
|
|
Academic Article
|
Peripheral cytokines are not influenced by the type of surgical approach for non-small cell lung cancer by four weeks postoperatively.
|
|
Academic Article
|
Genomic assessment distinguishes intrapulmonary metastases from synchronous primary lung cancers.
|
|
Academic Article
|
Perioperative considerations for neoadjuvant immunotherapy in non-small cell lung cancer.
|
|
Academic Article
|
Female Gender Predicts Augmented Immune Infiltration in Lung Adenocarcinoma.
|
|
Academic Article
|
Pathological nodal disease defines survival outcomes in patients with lung cancer with tumour major pathological response following neoadjuvant chemotherapy.
|
|
Academic Article
|
Emerging Therapies in Thoracic Malignancies-Immunotherapy, Targeted Therapy, and T-Cell Therapy in Non-Small Cell Lung Cancer.
|
|
Academic Article
|
Perioperative outcomes among chronic opioid users who receive lobectomy for non-small cell lung cancer.
|
|
Academic Article
|
Neoadjuvant Chemotherapy Increases Cytotoxic T Cell, Tissue Resident Memory T Cell, and B Cell Infiltration in Resectable NSCLC.
|
|
Academic Article
|
Liposomal Bupivacaine Intercostal Block Is Important for Reduction of Pulmonary Complications.
|
|
Academic Article
|
Predictors of survival following surgical resection of limited-stage small cell lung cancer.
|
|
Academic Article
|
Characterization of the Immune Landscape of EGFR-Mutant NSCLC Identifies CD73/Adenosine Pathway as a Potential Therapeutic Target.
|
|
Academic Article
|
CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma.
|
|
Academic Article
|
Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas.
|
|
Academic Article
|
Emerging biomarkers for neoadjuvant immune checkpoint inhibitors in operable non-small cell lung cancer.
|
|
Academic Article
|
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial.
|
|
Academic Article
|
Controversies and challenges in the pathologic examination of lung resection specimens after neoadjuvant treatment.
|
|
Academic Article
|
Correction to: CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma.
|
|
Academic Article
|
Impact of Psychiatric Comorbidities on Surgical Outcomes for Non-Small Cell Lung?Cancer.
|
|
Academic Article
|
Single-Cell Expression Landscape of SARS-CoV-2 Receptor ACE2 and Host Proteases in Normal and Malignant Lung Tissues from Pulmonary Adenocarcinoma Patients.
|
|
Academic Article
|
Robotic Surgery and Anatomic Segmentectomy: An Analysis of Trends, Patient Selection, and Outcomes.
|
|
Academic Article
|
Evaluation of Pathologic Response in Lymph Nodes of Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy.
|
|
Academic Article
|
Resolving the Spatial and Cellular Architecture of Lung Adenocarcinoma by Multiregion Single-Cell Sequencing.
|
|
Academic Article
|
Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular features.
|
|
Academic Article
|
Will radiotherapy be a future part of neoadjuvant therapy in operable non-small-cell lung cancer?
|
|
Academic Article
|
Pulmonary resection for tissue harvest in adoptive tumor-infiltrating lymphocyte therapy: Safety and feasibility.
|
|
Academic Article
|
Preoperative Maximum Standardized Uptake Value Associated With Recurrence Risk in Early Lung Cancer.
|
|
Academic Article
|
Modern Perioperative Practices May Mitigate Effects of Continued Smoking Among Lung Cancer Patients.
|
|
Academic Article
|
Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer.
|
|
Academic Article
|
Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer.
|
|
Academic Article
|
Lung Cancer Surgery After Neoadjuvant Immunotherapy or Targeted Therapy: Knowledge, Judgment, and Skills Refined.
|
|
Academic Article
|
The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristics.
|
|
Academic Article
|
Preoperative and Postoperative Systemic Therapy for Operable Non-Small-Cell Lung Cancer.
|
|
Academic Article
|
Surgical approach does not influence changes in circulating immune cell populations following lung cancer resection.
|
|
Academic Article
|
Combined IL-2, agonistic CD3 and 4-1BB stimulation preserve clonotype hierarchy in propagated non-small cell lung cancer tumor-infiltrating lymphocytes.
|
|
Academic Article
|
Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non-small cell lung cancer.
|
|
Academic Article
|
Current Surgical Indications for Non-Small-Cell Lung Cancer.
|
|
Academic Article
|
Barriers to surveillance imaging adherence in early-staged lung cancer.
|
|
Academic Article
|
Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLC.
|
|
Academic Article
|
The Role of Surgery in the Treatment of Melanoma Pulmonary Metastases in the Modern Era.
|
|
Academic Article
|
Role of neoadjuvant chemoimmunotherapy for resectable NSCLC.
|
|
Academic Article
|
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma.
|
|
Academic Article
|
Limited Benefit from the Addition of Immunotherapy to Chemotherapy in TKI-Refractory EGFR-Mutant Lung Adenocarcinoma.
|
|
Academic Article
|
Repeated Pulmonary Metastasectomy: Third?Operations and Beyond.
|
|
Academic Article
|
Immunogenomic profiling of lung adenocarcinoma reveals poorly differentiated tumors are associated with an immunogenic tumor microenvironment.
|
|
Academic Article
|
The Single-Cell Immunogenomic Landscape of B and Plasma Cells in Early-Stage Lung Adenocarcinoma.
|
|
Academic Article
|
The role of immunotherapy and targeted therapy in the multimodal therapy for resectable lung cancer.
|
|
Academic Article
|
Intraoperative challenges after induction therapy for non-small cell lung cancer: Effect of nodal disease on technical complexity.
|
|
Academic Article
|
Shared Nearest Neighbors Approach and Interactive Browser for Network Analysis of a Comprehensive Non-Small-Cell Lung Cancer Data Set.
|
|
Academic Article
|
Major Pathologic Response and Prognostic Score Predict Survival in Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy.
|
|
Academic Article
|
Optimal Combination of Neuroendocrine Markers for the Detection of High-Grade Neuroendocrine Tumors of the Sinonasal Tract and Lung.
|
|
Academic Article
|
Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer.
|
|
Academic Article
|
Analysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of?Recurrence in Stage I Non-Small Cell Lung Cancer.
|
|
Academic Article
|
Surgical Approach and Persistent Opioid Use in Medicare Patients Undergoing Lung Cancer Resection.
|
|
Academic Article
|
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial.
|
|
Academic Article
|
Disparities in early-stage lung cancer outcomes at minority-serving hospitals compared with nonminority serving hospitals.
|
|
Academic Article
|
The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non-small cell lung cancer.
|
|
Academic Article
|
Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study.
|
|
Academic Article
|
Perspectives, risk factors, and coping mechanisms in patients with self-reported financial burden following lung cancer surgery.
|
|
Academic Article
|
Financial Toxicity in Patients With Resected Lung Cancer.
|
|
Academic Article
|
Neoadjuvant Targeted Therapy in Resectable NSCLC: Current and Future Perspectives.
|
|
Academic Article
|
Lung surveillance following colorectal cancer pulmonary metastasectomy: Utilization of clinicopathologic risk factors to guide strategy.
|
|
Academic Article
|
Perioperative and oncologic outcomes of pulmonary resection for synchronous oligometastatic non-small cell lung cancer: Evidence for surgery in advanced disease.
|
|
Academic Article
|
International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy.
|
|
Academic Article
|
Impact of travel distance on receipt of indicated adjuvant therapy in resected non-small cell lung cancer.
|
|
Academic Article
|
Surgical outcomes after chemotherapy plus nivolumab and chemotherapy plus nivolumab and ipilimumab in patients with non-small cell lung cancer.
|
|
Academic Article
|
Pathologic Processing of Lung Cancer Resection Specimens After Neoadjuvant Therapy.
|
|
Academic Article
|
Do resected colorectal cancer patients need early chest imaging? Impact of clinicopathologic characteristics on time to development of pulmonary metastases.
|
|
Academic Article
|
NEOSTAR trial and the current status of neoadjuvant therapy in non-small cell lung cancer.
|
|
Academic Article
|
Circulomic variables predict pathologic staging preoperatively in treatment-na?ve non-small cell lung cancer.
|
|
Academic Article
|
Circulating tumor DNA and radiological tumor volume identify patients at risk for relapse with resected, early-stage non-small-cell lung cancer.
|
|
Academic Article
|
Transitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: Trends and Surgical Outcomes in a Regionalized Pulmonary Oncology Network.
|
|
Academic Article
|
An atlas of epithelial cell states and plasticity in lung adenocarcinoma.
|
|
Academic Article
|
Synthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of concept.
|
|
Academic Article
|
Author Correction: An atlas of epithelial cell states and plasticity in lung adenocarcinoma.
|